4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-009345
CHIEF OPERATING OFFICER acquired 1,048 shares (grant or award)
- CHIEF OPERATING OFFICER gave up 577 shares (to pay taxes)
- CHIEF OPERATING OFFICER acquired 1,964 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2022-07-15 | Grant or award | +1,048 | $9.56 | $10,019 | 113,261 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2022-09-02 | Option exercise | +1,964 | 115,225 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2022-09-02 | Shares withheld for taxes | −577 | $11.44 | $6,601 | 114,648 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2022-09-01 | Grant or award · Share Option | +65,420 | 65,420 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2022-09-01 | Grant or award · Restricted Share Unit | +10,905 | 10,905 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2022-09-02 | Option exercise · Restricted Share Unit | −1,964 | 5,892 | D | ||
Loading xslF345X03/form4-09062022_010905.xml…